1. Regimens to treat multidrug-resistant tuberculosis: past, present and future perspectives

   Global TB Network Clinical Trials, Pontali, E., Raviglione, M. C. & Migliori, G. B., 30-Jun-2019, In : European Respiratory Review. 28, 152, 7 p., 190035.

   Research output: Contribution to journal › Review article › Academic › peer-review

2. Regimen design and pharmacokinetic-pharmacodynamic science: lessons learned

   Alffenaar, J-W. C., Tiberi, S. & Migliori, G. B., Jan-2019, In : Lancet Infectious Diseases. 19, 1, p. 3-4 3 p.

   Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

3. Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study

   members of the International Study Group on new anti-tuberculosis drugs and adverse events monitoring, Jun-2019, In : International Journal of Infectious Diseases. 83, p. 72-76 5 p.

   Research output: Contribution to journal › Article › Academic › peer-review

4. Clinical Management of Multidrug-Resistant Tuberculosis in 16 European Countries

   TBnet, 1-Aug-2018, In : American Journal of Respiratory and Critical Care Medicine. 198, 3, p. 379-386 8 p.

   Research output: Contribution to journal › Article › Academic › peer-review

5. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: An individual patient data meta-analysis

   Collaborative Grp Meta-Analysis In, 8-Sep-2018, In : LANCET. 392, 10150, p. 821-834 14 p.

   Research output: Contribution to journal › Article › Academic › peer-review

View all (8) »